Cargando…

Respiratory syncytial virus hospitalization trends in infants with chronic lung disease of infancy, 1998–2008

OBJECTIVE: Infants with chronic lung disease of infancy (CLDI) are at high risk for severe respiratory syncytial virus (RSV) illness requiring hospitalization. Palivizumab was first licensed in 1998 for the prevention of RSV disease in high-risk infants, including those with CLDI. We performed a ret...

Descripción completa

Detalles Bibliográficos
Autores principales:	Groothuis, Jessie R, Fryzek, Jon P, Makari, Doris, Steffey, Duane, Martone, William J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191114/ https://www.ncbi.nlm.nih.gov/pubmed/22003308 http://dx.doi.org/10.2147/CLEP.S17189

Ejemplares similares

The Underrecognized Burden of Respiratory Syncytial Virus Among Infants Presenting to US Emergency Departments
por: Makari, Doris, et al.
Publicado: (2015)

Modeling the Potential Impact of the 2014 American Academy of Pediatrics Respiratory Syncytial Virus Prophylaxis Guidance on Preterm Infant RSV Outcomes
por: McLaurin, Kimmie K., et al.
Publicado: (2015)

Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997–2012
por: Doucette, Abigail, et al.
Publicado: (2016)

Evaluation of recent New Vaccine Surveillance Network data regarding respiratory syncytial virus hospitalization rates in US preterm infants
por: DeVincenzo, John P., et al.
Publicado: (2016)

Rationale for full-season dosing for passive antibody prophylaxis of respiratory syncytial virus
por: Makari, Doris, et al.
Publicado: (2014)

Respiratory Syncytial Virus and All-Cause Bronchiolitis Hospitalizations Among Preterm Infants Using the Pediatric Health Information System (PHIS)
por: Fergie, Jaime, et al.
Publicado: (2020)

Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age
por: Movva, Naimisha, et al.
Publicado: (2022)

Mortality Among US Infants and Children Under 5 Years of Age with Respiratory Syncytial Virus and Bronchiolitis: A Systematic Literature Review
por: Bylsma, Lauren C, et al.
Publicado: (2022)

Prevention of serious respiratory syncytial virus-related illness. I: Disease pathogenesis and early attempts at prevention
por: Groothuis, Jessie R., et al.
Publicado: (2011)

Respiratory Syncytial Virus Bronchiolitis in Infancy: The Acute Hospitalization Cost
por: Bozzola, Elena, et al.
Publicado: (2021)

Respiratory Syncytial Virus Disease in Preterm Infants in the US Born at 32–35 Weeks Gestation Not Receiving Immunoprophylaxis
por: Ambrose, Christopher S., et al.
Publicado: (2014)

1636. Prevention of respiratory syncytial virus hospitalizations (RSVH) in US infants who paid through Medicaid would have a disproportionate benefit for Black, Hispanic, Asian/Pacific Islander, Native American and Other race/ethnicity infants, and have a substantial impact on overall RSVH burden and related costs: Rates of respiratory syncytial virus hospitalization (RSVH) among US infants by race/ethnicity and insurance payer, NIS 2018-2020
por: Nelson, Christopher B, et al.
Publicado: (2023)

A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year( )
por: Suh, Mina, et al.
Publicado: (2022)

Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009–2019: A Study of the National (Nationwide) Inpatient Sample
por: Suh, Mina, et al.
Publicado: (2022)

Hospitalizations for Respiratory Syncytial Virus Among Adults in the United States, 1997–2012
por: Pastula, Susan T., et al.
Publicado: (2017)

Association between respiratory syncytial virus hospitalization in infancy and childhood asthma
por: Coutts, Jonathan, et al.
Publicado: (2020)

Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011–2019
por: Suh, Mina, et al.
Publicado: (2022)

Mortality Associated With Respiratory Syncytial Virus, Bronchiolitis, and Influenza Among Infants in the United States: A Birth Cohort Study From 1999 to 2018
por: Reichert, Heidi, et al.
Publicado: (2022)

1406. Comparison of Clinical Presentations and Burden of Respiratory Syncytial Virus in Infants Across Three Distinct Healthcare Settings
por: Rankin, Danielle A, et al.
Publicado: (2020)

The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children
por: Simões, Eric A.F., et al.
Publicado: (2010)

Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses
por: Friedman, Deborah, et al.
Publicado: (2017)

Trends in Hospitalized Acute Myocardial Infarction Patients with Heart Failure in Korea at 1998 and 2008
por: Youn, Jong-Chan, et al.
Publicado: (2014)

Trends in healthy life expectancy among older Brazilian women between 1998 and 2008
por: Nepomuceno, Marília Regina, et al.
Publicado: (2015)

Safety and Effectiveness of Palivizumab in Children at High Risk of Serious Disease Due to Respiratory Syncytial Virus Infection: A Systematic Review
por: Wegzyn, Colleen, et al.
Publicado: (2014)

Challenges to Evaluating Respiratory Syncytial Virus Mortality in Bangladesh, 2004–2008
por: Stockman, Lauren J., et al.
Publicado: (2013)

Severe respiratory disease caused by human respiratory syncytial virus impairs language learning during early infancy
por: Peña, Marcela, et al.
Publicado: (2020)

Gene therapy of the rheumatic diseases: 1998 to 2008
por: Evans, Christopher H, et al.
Publicado: (2009)

The disease burden of respiratory syncytial virus in Infants
por: Munro, Alasdair P.S., et al.
Publicado: (2023)

Comparison of clinical presentations and burden of respiratory syncytial virus in infants across three distinct healthcare settings in Davidson County, Tennessee
por: Rankin, Danielle A., et al.
Publicado: (2022)

Population-based trends and underlying risk factors for infant respiratory syncytial virus and bronchiolitis hospitalizations
por: Bennett, Mihoko V., et al.
Publicado: (2018)

RESPIRATORY SYNCYTIAL AND OTHER VIRUSES ASSOCIATED WITH RESPIRATORY DISEASE IN INFANTS
por: Jacobs, J.W., et al.
Publicado: (1971)

Type I Interferon Potentiates IgA Immunity to Respiratory Syncytial Virus Infection During Infancy
por: Hijano, Diego R., et al.
Publicado: (2018)

Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
por: Pavilack, Melissa, et al.
Publicado: (2017)

Ciguatera Fish Poisoning in the Pacific Islands (1998 to 2008)
por: Skinner, Mark P., et al.
Publicado: (2011)

Epidemiology of Respiratory Syncytial Virus Infection in Preterm Infants
por: Resch, Bernhard, et al.
Publicado: (2011)

Respiratory Syncytial Virus Infection in High-Risk Infants
por: Resch, Bernhard
Publicado: (2011)

Detection of respiratory syncytial virus and rhinovirus in healthy infants
por: Hasegawa, Kohei, et al.
Publicado: (2015)

Respiratory syncytial virus infection in infants in rural Nepal
por: Chu, Helen Y., et al.
Publicado: (2016)

Randomized, Double-Blind Study of the Safety of the Liquid Versus Lyophilized Formulation of Palivizumab in Premature Infants and Children with Chronic Lung Disease of Prematurity
por: Makari, Doris, et al.
Publicado: (2014)

Infancy and Infant-Rearing
Publicado: (1895)

Cannot write session to /tmp/vufind_sessions/sess_folt3m8pc976ajcpk5qb3gb8cq